excessive gas semaglutide burping: why it happens and how to stop it How to Manage (or Prevent)

These efforts have led to the development of various GLP-1 receptor agonists, the most recent being semaglutide and tirzepatide, approved for the treatment of type 2 diabetes in 2018 and 2022, respectively

Hypersensitivity reactions Severe allergic reactions have been reported in rare cases

By activating glucagon-like peptide-1 (GLP-1) receptors, it reduces appetite, increases feelings of fullness, and aids in weight loss

A key safety concern among researchers is that CJC-1295 has an extremely long half-life of 6-10 days

With proper use of Semaglutide, along with balanced eating and light exercise, blood sugar control becomes easier and more stable